JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 7, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/50/46864    most recent
M107943200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klezovitch, O.
Right arrow Articles by Scanu, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klezovitch, O.
Right arrow Articles by Scanu, A. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print October 8, 2001
J. Biol. Chem, 10.1074/jbc.M107943200
Submitted on August 17, 2001
Revised on October 8, 2001
Accepted on October 8, 2001

Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein (a): evidence for a critical involvement of elements in its C-terminal domain

Olga Klezovitch, Celina Edelstein, and Angelo M. Scanu

Department of Medicine, University of Chicago, Chicago, IL 60637

Corresponding Author: ascanu{at}medicine.bsd.uchicago.edu

In the vessel wall, macrophages are among the cells that upon activation contribute to the atherosclerotic process. Low density lipoproteins (LDL) can mediate this activation but only after enzymatic or oxidative modification. Lipoprotein(a), (Lp(a)), is an LDL variant that has been shown to have an atherogenic potential by no clearly established mechanisms. In the present study we examined whether native Lp(a) can activate macrophages and, if so, identify the structural elements involved in this action. For this purpose, we utilized human THP-1 macrophages, prepared by treating THP-1 monocytes with phorbol ester and exposed them to Lp(a) and its two derivatives: apo(a)-free LDL (Lp(a-)) and free apo(a). We also studied apo(a) fragments, F1(N-terminal) and F2 (C-terminal) and sub-fragments thereof, obtained by leukocyte elastase digestion. By Northern blot analyses, Lp(a), but not Lp(a-), caused up to 12-fold increase in interleukin 8 (IL-8) mRNA as compared to untreated cells. Free apo(a) also induced the production of IL-8 mRNA; however, the effect was 3-4 fold higher than that of Lp(a). The increase in mRNA was associated with the accumulation of IL-8 protein in the culture medium. F1 had only a minimal effect whereas F2 was 1.5-2 fold more potent than apo(a), an activity mostly contained in the KV-protease region. A monoclonal antibody specific for KV, inhibited the apo(a)-mediated effect on IL-8. We conclude that Lp(a) via elements contained in the C-terminal domain of apo(a), causes in THP-1 macrophages an increased production of IL-8, a chemokine with pro-inflammatory properties, an event that may be relevant to the process of atherosclerosis.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Tsimikas, L. D. Tsironis, and A. D. Tselepis
New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A2 in Atherosclerosis and Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2094 - 2099.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Edelstein, M. Yousef, and A. M. Scanu
Elements in the C terminus of apolipoprotein [a] responsible for the binding to the tenth type III module of human fibronectin
J. Lipid Res., December 1, 2005; 46(12): 2673 - 2680.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Tsimikas, E. S. Brilakis, E. R. Miller, J. P. McConnell, R. J. Lennon, K. S. Kornman, J. L. Witztum, and P. B. Berger
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
N. Engl. J. Med., July 7, 2005; 353(1): 46 - 57.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Yagyu, H. Kobayashi, H. Matsuzaki, K. Wakahara, T. Kondo, N. Kurita, H. Sekino, K. Inagaki, M. Suzuki, N. Kanayama, et al.
Thalidomide Inhibits Tumor Necrosis Factor-{alpha}-Induced Interleukin-8 Expression in Endometriotic Stromal Cells, Possibly through Suppression of Nuclear Factor-{kappa}B Activation
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3017 - 3021.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. H. O'Neil, M. B. Boffa, M. A. Hancock, J. G. Pickering, and M. L. Koschinsky
Stimulation of Vascular Smooth Muscle Cell Proliferation and Migration by Apolipoprotein(a) Is Dependent on Inhibition of Transforming Growth Factor-{beta} Activation and on the Presence of Kringle IV Type 9
J. Biol. Chem., December 31, 2004; 279(53): 55187 - 55195.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Edelstein, D. Pfaffinger, J. Hinman, E. Miller, G. Lipkind, S. Tsimikas, C. Bergmark, G. S. Getz, J. L. Witztum, and A. M. Scanu
Lysine-Phosphatidylcholine Adducts in Kringle V Impart Unique Immunological and Potential Pro-inflammatory Properties to Human Apolipoprotein(a)
J. Biol. Chem., December 26, 2003; 278(52): 52841 - 52847.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.